Clinical Trial Detail

NCT ID NCT02057770
Title Allogeneic or Haploidentical Stem Cell Transplant Followed By High-Dose Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

acute myeloid leukemia

Therapies

Busulfan + Cyclophosphamide + Fludarabine

Tocilizumab

Age Groups: senior adult

No variant requirements are available.